Imaging for Cardiovascular Disease

Recruiting in Palo Alto (17 mi)

Overseen byRukhsana Mirza, MD

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Recruiting

Sponsor: Northwestern University

No Placebo Group

Trial Summary

What is the purpose of this trial?This study aims to determine whether changes in retinal vasculature seen on SS-OCTA can be correlated to degree of cardiovascular disease as measured by carotid duplex ultrasonography.

Eligibility Criteria

This trial is for adults aged 18-80 who are being checked for heart disease and can undergo a clinical eye exam. They must be able to consent, not have any known eye diseases except for needing glasses or contacts, and should be getting standard carotid artery scans.

Inclusion Criteria

Able to participate in a clinical eye examination setting.

Subjects receiving standard of care carotid duplex ultrasounds.

Able to consent.

+2 more

Exclusion Criteria

Subjects younger than 18 years of age or older than 80 years of age.

You have had a stroke or sudden loss of vision in the past.

Lack of capacity to provide informed consent.

+2 more

Participant Groups

The study is testing if a special type of eye scan called SS-OCTA can show changes in the tiny blood vessels of the retina that match up with how severe someone's heart disease is, as seen on neck artery ultrasounds.

1Treatment groups

Experimental Treatment

Group I: All ParticipantsExperimental Treatment1 Intervention

50 participants identified in the Northwestern Medicine Division of Vascular Surgery.